The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $41.48

Today's change+0.14 +0.34%
Updated February 21 11:23 AM EST. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $41.48

Today's change+0.14 +0.34%
Updated February 21 11:23 AM EST. Delayed by at least 15 minutes.

GlaxoSmithKline PLC Hits New 50-day High

GlaxoSmithKline PLC is up today by (U.S.)$0.14 or 0.34% to (U.S.)$41.48 and setting a new 50-day high. Over the last five days, shares have gained 3.42% and 7.71% year to date. Shares have underperformed the S&P 500 by 18.88% during the last year.

Key company metrics

  • Open(U.S.) $41.42
  • Previous close(U.S.) $41.34
  • High(U.S.) $41.49
  • Low(U.S.) $41.31
  • Bid / Ask(U.S.) $41.47 / (U.S.) $41.48
  • YTD % change+7.71%
  • Volume1,850,799
  • Average volume (10-day)4,204,009
  • Average volume (1-month)3,714,507
  • Average volume (3-month)3,927,944
  • 52-week range(U.S.) $37.20 to (U.S.) $45.58
  • Beta0.96
  • Trailing P/E90.28×
  • P/E 1 year forward14.92×
  • Forward PEG1.09×
  • Indicated annual dividend(U.S.) $2.66
  • Dividend yield6.42%
  • Trailing EPS(U.S.) $0.46
Updated February 21 11:23 AM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue7,5867,5426,5326,229
Total other revenue--------
Total revenue7,5867,5426,5326,229
Gross profit5,2575,0994,4764,159
Total cost of revenue2,3292,4432,0562,070
Total operating expense6,9916,1116,6835,506
Selling / general / administrative2,4762,2322,0752,076
Research & development1,017876800775
Depreciation / amortization10111010
Interest expense (income), net operating--------
Unusual expense (income)1,2766561,825666
Other operating expenses, total-117-107-83-91
Operating income5951,431-151723
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax4231,274-318560
Income after tax317885-492352
Income tax, total106389174208
Net income257808-435282
Total adjustments to net income--------
Net income before extra. items257808-435282
Minority interest-60-7757-70
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items257808-435282
Inc. avail. to common incl. extra. items257808-435282
Diluted net income257809-435282
Dilution adjustment01--0
Diluted weighted average shares4,9574,9024,8594,890
Diluted EPS excluding extraordinary itemsvalue per share0.050.17-0.090.06
Dividends per sharevalue per share0.230.190.190.19
Diluted normalized EPSvalue per share0.250.260.150.14